Literature DB >> 31833722

Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: a large retrospective study.

Marco Sebben1, Alessandro Tafuri1,2, Marco Pirozzi1, Tania Processali1, Riccardo Rizzetto1, Nelia Amigoni1, Aliasger Shakir2, Mario De Michele1, Andrea Panunzio1, Clara Cerrato1, Leone Tiso1, Giovanni Novella1, Matteo Brunelli3, Filippo Migliorini1, Vincenzo De Marco1, Salvatore Siracusano1, Walter Artibani1, Antonio B Porcaro4.   

Abstract

BACKGROUND: The aim of this study is to evaluate factors (clinical, pathological and perioperative) associated with the risk of hospital readmission after radical prostatectomy (RP) over the long term in a single tertiary referral center where both open RP (ORP) and robot assisted RP (RARP) are performed.
METHODS: From January 2013 to December 2018 patients older than 18 years, who provided signed consent and underwent open or robot assisted radical prostatectomy were enrolled and retrospectively evaluated. Patients who underwent any previous prostate cancer (PCA) treatments were excluded. Specifically, skilled and experienced surgeons performed the two surgical approaches. Patients were followed for complications and hospital readmission (RAD) for a period of six months. The association of factors with the risk of readmission was assessed by Cox's multivariate proportional hazards.
RESULTS: A total of 1062 patients underwent RP. RARP was performed in 891 cases and ORP in 171 subjects. Extended pelvic lymph node dissection (ePLND) was performed in 651 patients. Hospital readmission occurred in 53 cases (5%). Based on the final multivariate model, independent factors associated with the risk of hospital readmission were seminal vesicle invasion (HR=2.093; 95% CI: 1.177-3.722), ORP (HR=4.393; 95% CI: 2.516-7.672) and ePLND (HR=4.418; 95% CI: 1.544-12.639).
CONCLUSIONS: ORP, ePLND and seminal vesicle invasion are independent predictors of the risk of hospital readmission over the long term at a large single tertiary referral center. When surgery is chosen as a primary treatment of PCA, patients should be informed of the risk of hospital readmission and related risk factors. Assessing seminal vesicle invasion by preoperative clinical staging identifies locally advanced disease, which is associated with an increased risk of hospital readmission.

Entities:  

Year:  2019        PMID: 31833722     DOI: 10.23736/S0393-2249.19.03586-0

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  3 in total

1.  Development of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy only.

Authors:  Cristian Fiori; Enrico Checcucci; Ilaria Stura; Daniele Amparore; Sabrina De Cillis; Alberto Piana; Stefano Granato; Gabriele Volpi; Michele Sica; Federico Piramide; Paolo Verri; Matteo Manfredi; Stefano De Luca; Riccardo Autorino; Giuseppe Migliaretti; Francesco Porpiglia
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-06-24       Impact factor: 5.554

2.  Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies.

Authors:  Mattia Luca Piccinelli; Stefano Luzzago; Giulia Marvaso; Ekaterina Laukhtina; Noriyoshi Miura; Victor M Schuettfort; Keiichiro Mori; Abdulmajeed Aydh; Matteo Ferro; Francesco A Mistretta; Nicola Fusco; Giuseppe Petralia; Barbara A Jereczek-Fossa; Shahrokh F Shariat; Pierre I Karakiewicz; Ottavio de Cobelli; Gennaro Musi
Journal:  World J Urol       Date:  2021-10-23       Impact factor: 4.226

3.  Predictors of complications occurring after open and robot-assisted prostate cancer surgery: a retrospective evaluation of 1062 consecutive patients treated in a tertiary referral high volume center.

Authors:  Antonio Benito Porcaro; Alessandro Tafuri; Riccardo Rizzetto; Nelia Amigoni; Marco Sebben; Aliasger Shakir; Katia Odorizzi; Alessandra Gozzo; Sebastian Gallina; Alberto Bianchi; Paola Irene Ornaghi; Stefano Zecchini Antoniolli; Vincenzo Lacola; Matteo Brunelli; Filippo Migliorini; Maria Angela Cerruto; Salvatore Siracusano; Walter Artibani; Alessandro Antonelli
Journal:  J Robot Surg       Date:  2021-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.